ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Twice Weekly Valganciclovir for Cytomegalovirus Infection Prophylaxis in Kidney Transplant Recipients with Delayed Graft Function on Hemodialysis

S. A. Mehta1, A. Katz2, R. Dieter2, P. Jen2, J. Siegfried2, J. Papadopoulos2, T. Lewis2

1Infectious Diseases, NYU Langone Health, New York, NY, 2Pharmacy, NYU Langone Health, New York, NY

Meeting: 2020 American Transplant Congress

Abstract number: A-190

Keywords: Cytomeglovirus, Kidney, N/A, Prophylaxis

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session A: All Infections (Excluding Kidney & Viral Hepatitis)

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • African American Race Is an Independent Risk Factor for Cytomegalovirus Infection in Renal Transplant Recipients on Low-Dose Valganciclovir Prophylaxis
  • Cytomegalovirus Prophylaxis Following Alemtuzumab Induction in High Risk Renal Transplant Recipients Experiencing Delayed Graft Function

*Purpose: The incidence of cytomegalovirus (CMV) remains high in the first year following kidney transplantation. Valganciclovir (VGC) is commonly prescribed in the early post-operative period in order to prevent complications related to CMV. Outcomes in kidney transplant recipients experiencing delayed graft function (DGF) on hemodialysis (HD) receiving a renally dose adjusted regimen of VGC remains unknown.

*Methods: This is a single-center, retrospective review of of CMV viremia among deceased donor kidney transplant (DDKT) recipients with DGF requiring hemodialysis (HD) receiving VGC 450 mg twice weekly compared to patients with immediate graft function (IGF) who received initial daily VGC prophylaxis following transplant. The primary endpoint was the rate of CMV viremia during the first 12 months post-transplant. Secondary outcomes included the time from transplant to CMV viremia and the time from completion of prophylaxis to CMV viremia. Data analysis was performed using SPSS Statistics Software (Chicago, IL; version 25).

*Results: CMV viremia occurred while on prophylactic VGC at a median of 68 days (65-70) in 2 patients in the DGF group and in no patients in the IGF group. After completing prophylactic therapy, CMV viremia occurred in 30 DGF patients and 10 IGF patients (42% vs. 33%, p=0.43). In the DGF group and the IGF group, the median time to CMV positivity from transplant was 210 days (155-262) and 260 days (221-297), respectively. The median time to CMV positivity from prophylaxis therapy completion was 71 days (42-162) in the DGF group and 126 days (42-205) in the IGF group. One patient in the DGF group developed VGC-resistant CMV confirmed by genotype testing. Univariate analysis demonstrated that age >60, lymphopenia at the end of therapy and induction with anti-thymocyte globulin were associated with the development of CMV.

*Conclusions: There were similar rates of CMV viremia in DGF DDKT recipients as compared to those with IGF, regardless of CMV risk status. Larger studies are warranted to further explore whether a difference exists when renal adjusted VCG is used.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Mehta SA, Katz A, Dieter R, Jen P, Siegfried J, Papadopoulos J, Lewis T. Twice Weekly Valganciclovir for Cytomegalovirus Infection Prophylaxis in Kidney Transplant Recipients with Delayed Graft Function on Hemodialysis [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/twice-weekly-valganciclovir-for-cytomegalovirus-infection-prophylaxis-in-kidney-transplant-recipients-with-delayed-graft-function-on-hemodialysis/. Accessed March 8, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Search
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.